Skip to main content

Security report for natcopharma.ca

Natco Pharma (Canada) Inc. · Healthcare · Canada

Medium risk. 6 critical or high findings in Security headers, GDPR outside view and 1 other check.

Security score

55/100

Risk levelMedium

0–100, higher is better. How it is calculated

Natco Pharma (Canada) Inc. is a Canadian subsidiary of Natco Pharma Limited, specializing in pharmaceutical manufacturing and supply. The company emphasizes vertical integration, controlling all stages from active pharmaceutical ingredients to finished dosage forms, ensuring quality and affordability. Established since 2006, Natco Pharma serves Canadian patients with a portfolio of globally approved medicines, positioning itself as a trusted pharmaceutical supplier in Canada. The website reflects a professional corporate presence with clear business information and regulatory trust indicators. Technically, the website is built on WordPress with WooCommerce and uses modern web technologies such as WPBakery Page Builder and Revolution Slider. The site is mobile optimized and includes SEO best practices, although some accessibility features are basic. Performance is moderate, with external dependencies on common CDNs and Google Analytics for tracking. From a security perspective, the site enforces HTTPS and uses secure plugins but lacks important security headers and a cookie consent mechanism, which impacts privacy compliance. No incident response or vulnerability disclosure information is provided, which could be improved to enhance trust. The absence of WHOIS data for the domain raises concerns about domain registration transparency, although the business legitimacy is supported by regulatory approvals and professional content. Overall, Natco Pharma (Canada) Inc. presents a credible pharmaceutical business with a solid digital presence but would benefit from enhanced security practices and privacy compliance measures to strengthen trust and regulatory adherence.

Scanned

NIS2 and GDPR posture

GDPR outside view
58/ 100 · Medium
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

6 findings rated critical or high. Fix these first.

  1. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing Strict-Transport-Security header

      Forces HTTPS connections

      What to do: Add "Strict-Transport-Security: max-age=31536000; includeSubDomains; preload"

      • CWE-319
      • OWASP A04:2025
      • ASVS V3.4.1
    • High

      Missing X-Frame-Options header

      Prevents clickjacking attacks

      What to do: Add "X-Frame-Options: DENY" or "X-Frame-Options: SAMEORIGIN"

    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…

  2. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • High

      No Cookie Policy found

      GDPR requires clear information about cookie usage

      What to do: Add a dedicated cookie policy explaining cookie usage and purposes

    • High

      No Cookie Consent Banner found

      GDPR requires explicit consent for non-essential cookies

      What to do: Implement a cookie consent banner that appears on first visit

Need hands-on remediation? Email guard@offseq.com

Keep watching natcopharma.ca

This scan found 22 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
95
Security headers
15
Email security
70
DNS health
70
Network security
20
GDPR outside view
58
Average
55

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

Natco Pharma (Canada) Inc. operates in the healthcare sector as a pharmaceutical manufacturer and supplier, leveraging vertical integration to control product quality and cost. The company targets Canadian healthcare providers and patients, offering a range of medicines approved by multiple international regulators. Its business model focuses on R&D and manufacturing, supported by a parent company with a global footprint. The website indicates a medium-sized enterprise with a consistent brand and clear market positioning. The presence of a medication returns program and multiple product offerings suggests a comprehensive service portfolio. The company maintains a LinkedIn presence, indicating engagement with professional networks. However, the lack of detailed financial or corporate governance information limits deeper business intelligence insights.

Security posture

The website demonstrates a moderate security posture with HTTPS enabled and no visible exposure of sensitive data. However, the absence of key security headers such as Content-Security-Policy, X-Frame-Options, and X-XSS-Protection reduces protection against common web attacks. The lack of a cookie consent mechanism and privacy compliance features indicates gaps in regulatory adherence, particularly GDPR. No incident response or vulnerability disclosure channels are provided, limiting the ability to report or respond to security issues. The use of popular and maintained plugins reduces risk but requires ongoing monitoring. Overall, the security maturity is moderate but could be significantly improved with standard best practices and transparency measures.

Recommendations

  1. Implement essential security headers (Content-Security-Policy, X-Frame-Options, X-XSS-Protection) to enhance web security.
  2. Add a cookie consent banner and privacy compliance features to meet GDPR and other privacy regulations.
  3. Publish a security policy and incident response contact information to improve transparency and trust.
  4. Create and maintain a security.txt file to facilitate vulnerability disclosure and responsible reporting.
  5. Verify and update domain WHOIS information to ensure registration transparency and improve domain trustworthiness.

Contact details published on the site

Addresses
Legal name
Natco Pharma (Canada) Inc.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Natco Pharma (Canada) Inc.
Description
Natco Pharma (Canada) Inc. is the Canadian subsidiary of Natco Pharma Limited. We are a vertically integrated pharmaceutical company focused on R&D and the manufacturing of drug products.
Key services
Pharmaceutical manufacturing, Research and Development, Drug product supply, Medication returns program
Content quality
good
Branding
consistent

Technology

Stack
WordPress, WooCommerce, WPBakery Page Builder, Revolution Slider, jQuery, Owl Carousel, Font Awesome
Frameworks
WooCommerce
Platforms
WordPress
Performance
moderate
Mobile
good
Accessibility
basic
SEO
good

Security

Observed score
75/100
Good practices seen
  • HTTPS enforced
  • No exposed sensitive data in HTML
  • Use of secure plugins and libraries

Analytics and tracking

Services
Google Analytics
Tracking level
moderate
Privacy practices
basic

Advertising

Transparency
basic

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high

Key observations

  1. Website is a WordPress-based pharmaceutical company site with WooCommerce components.
  2. Content is professionally presented with clear business focus on pharmaceutical manufacturing and supply.
  3. No WHOIS data available, which is unusual and reduces domain trust score.
  4. No visible cookie consent mechanism despite use of tracking scripts.
  5. No explicit security headers detected in HTML source.
  6. Contact information is clearly provided including physical address and phone numbers.
  7. Privacy policy is present but basic; no terms of service or security policy pages found.
  8. No incident response or vulnerability disclosure information available.
  9. Site uses modern web technologies and is mobile optimized.
  10. No adult or questionable content detected.
Technical notes

Notes

The website is built on a WordPress CMS platform with WooCommerce for e-commerce capabilities. It uses WPBakery Page Builder and Revolution Slider for content and visual presentation. The tech stack includes jQuery, Owl Carousel, and Font Awesome for UI components. External resources are loaded from trusted CDNs such as maxcdn.bootstrapcdn.com and fonts.googleapis.com. Google Analytics and Google Tag Manager are used for analytics and marketing. The site is mobile responsive with good SEO metadata and structured data (JSON-LD) for enhanced search engine understanding. Performance is moderate, with some opportunities for optimization. Accessibility features are basic and could be improved for compliance with standards. Hosting provider details are not explicitly identified from the content.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with natcopharma.ca. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review natcopharma.ca.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.